The purpose of this study is to describe representative real-world patterns of care for the management of invasive fungal infections (IFIs), including invasive mold infection (IMI). Specifically, the study goals are to examine real world patient characteristics and treatment patterns, associated healthcare resource utilization, and outcomes associated with use of mold-active triazoles (MATs) to treat invasive fungal infections (IFIs).
Study Type
OBSERVATIONAL
Enrollment
2,015
Treatment patterns of care assessed by reason for therapy
Assessments of patient patterns of care will be summarized by MAT treatment at baseline and overall.
Time frame: 5 years
Treatment patterns of care assessed by category of diagnosis at time of therapy initiation
Assessments of patient patterns of care will be summarized by MAT treatment at baseline and overall.
Time frame: 5 years
Treatment patterns of care assessed by onset of treatment/prophylaxis
Assessments of patient patterns of care will be summarized by MAT treatment at baseline and overall.
Time frame: 5 years
Treatment patterns of care assessed by length of treatment/prophylaxis
Assessments of patient patterns of care will be summarized by MAT treatment at baseline and overall.
Time frame: 5 years
Treatment patterns of care assessed by use of diagnostic method(s)
Assessments of patient patterns of care will be summarized by MAT treatment at baseline and overall.
Time frame: 5 years
Treatment patterns of care assessed by type of diagnostic method(s) used
Assessments of patient patterns of care will be summarized by MAT treatment at baseline and overall.
Time frame: 5 years
Treatment patterns of care assessed by use of therapeutic drug monitoring (TDM)
Assessments of patient patterns of care will be summarized by MAT treatment at baseline and overall.
Time frame: 5 years
Treatment patterns of care assessed by occurrence of drug-drug interactions (DDI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
University of Alabama - Birmingham
Birmingham, Alabama, United States
St. Joseph's Hospital
Phoenix, Arizona, United States
Mayo Clinic
Phoenix, Arizona, United States
University of Arizona
Tucson, Arizona, United States
University of California
Davis, California, United States
David Geffen School of Medicine
Los Angeles, California, United States
Stanford Health Care
Palo Alto, California, United States
Olive View UCLA Medical Center
Sylmar, California, United States
LA BioMed
Torrance, California, United States
University of Colorado
Aurora, Colorado, United States
...and 46 more locations
Assessments of patient patterns of care will be summarized by MAT treatment at baseline and overall.
Time frame: 5 years
Treatment patterns of care assessed by the sequence of invasive fungal infection treatment (IFI)
Assessments of patient patterns of care will be summarized by MAT treatment at baseline and overall.
Time frame: 5 years
Treatment patterns of care assessed by discontinuation due to adverse events (AEs) or other reasons
Assessments of patient patterns of care will be summarized by MAT treatment at baseline and overall.
Time frame: 5 years
Patient characteristics assessed by underlying host/risk factors
The summaries of patient characteristics will be by MAT treatment at baseline and overall.
Time frame: 5 years
Patient characteristics assessed by patient baseline characteristics
The summaries of patient characteristics will be by MAT treatment at baseline and overall.
Time frame: 5 years
Patient characteristics assessed by fungal disease diagnosis
The summaries of patient characteristics will be by MAT treatment at baseline and overall.
Time frame: 5 years
Patient characteristics assessed by pathogen treated
The summaries of patient characteristics will be by MAT treatment at baseline and overall.
Time frame: 5 years
Patient characteristics assessed by pathogen susceptibility
The summaries of patient characteristics will be by MAT treatment at baseline and overall.
Time frame: 5 years
Patient characteristics assessed by site of fungal infection
The summaries of patient characteristics will be by MAT treatment at baseline and overall.
Time frame: 5 years
Overall healthcare resource utilization assessed by hospitalization length of stay (LOS)
Assessments of overall healthcare resource inpatient utilization will be summarized
Time frame: 5 years
Overall healthcare resource utilization assessed by time spent in Intensive Care Unit (ICU)
Assessments of overall healthcare resource inpatient utilization will be summarized
Time frame: 5 years
Overall healthcare resource utilization assessed by time spent on ventilator in ICU
Assessments of overall healthcare resource inpatient utilization will be summarized
Time frame: 5 years
Overall healthcare resource utilization assessed by number of additional fungal specific diagnostics and interventions after MAT initiation
Assessments of overall healthcare resource inpatient utilization will be summarized
Time frame: 5 years
Overall healthcare resource utilization assessed by frequency of therapeutic drug monitoring (TDM)
Assessments of overall healthcare resource inpatient utilization will be summarized
Time frame: 5 years
Overall healthcare resource utilization assessed by incidence of discharge to a skilled nursing facility (SNF) or long term care (LTC) facility
Assessments of overall healthcare resource inpatient utilization will be summarized
Time frame: 5 years
Overall healthcare resource utilization assessed by length of stay at SNF or LTC facility
Assessments of overall healthcare resource inpatient utilization will be summarized
Time frame: 5 years
Overall healthcare resource utilization assessed by reason for admission to SNF or LTC facility
Assessments of overall healthcare resource inpatient utilization will be summarized
Time frame: 5 years
Overall healthcare resource utilization assessed by incidence of hospital readmissions at 30 and 90 days within a 5-year period
Assessments of overall healthcare resource inpatient utilization will be summarized
Time frame: 5 years
Overall healthcare resource utilization assessed by duration of hospital readmissions at 30 and 90 days within a 5-year period
Assessments of overall healthcare resource inpatient utilization will be summarized
Time frame: 5 years
Overall healthcare resource utilization assessed by outpatient utilization
Number of ED visits during the follow-up period
Time frame: 5 years
Overall healthcare resource utilization assessed by frequency of outpatient visits within 30 and 90 days within a 5-year period
Assessments of overall healthcare resource outpatient utilization will be summarized
Time frame: 5 years
Overall healthcare resource utilization assessed by primary reason for outpatient office visits within 30 and 90 days within a 5-year period
Assessments of overall healthcare resource outpatient utilization will be summarized
Time frame: 5 years